AMN107

Atom 1.0 15 New messages 50 New messages 15 New topics 50 New topics RSS 2.0 15 New messages 50 New

I have posted over 30 new articles today at http://cmlsupport.blogspot.com on various news CML

Dear Anjana Thankyou for your message.I will only be able to contemplate going back on the AMN 107,

Dear Barbara, My husband is on Gleevec and doing well, I am a friend of Ruth's. AMN107 trials are

I hope it will continue to go well Barbara. Rob ----- Original Message ----- From: Barbara Marfleet

Clinical trials are now recruiting patients for the new Merck drug VX-680 which has been developed to

2) Novartis Oncology is studying an investigational drug in patients with different types of Leukemia

New Drug For T315I Mutation Which Causes Gleevec Resistance Ambit Biosciences has announced the

----- Original Message ----- From: Barbara Marfleet To: AMN107...@cmlhope.com Sent: Saturday, July

AMN107 is a small molecule tyrosine kinase inhibitor developed, in the first instance, as a potent

Resistance to or intolerance of imatinib in patients with Philadelphia chromosome-positive chronic

That is great to hear you are doing well Ruth. Rob ----- Original Message ----- From: Ruth McIntosh

AMN107 is the new drug in clinical trials from Novartis for patients who do not respond well on

Welcome to the group Ruth. We are hoping to get some discussion here on the trials. Rob -----